Virtu Financial’s Verona Pharma VRNA Stock Holding History

Virtu Financial’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-35,703	Closed	-$3.81M	–	2289
2025 Q3	$3.81M	Buy	35,703 +31,568	+763%	+$3.3M	0.21%	88
2025 Q2	$391K	Sell	4,135 -6,791	-62%	-$503K	0.02%	657
2025 Q1	$694K	Buy	+10,926	New	+$654K	0.04%	392
2024 Q2	–	Sell	-23,180	Closed	-$373K	–	1920
2024 Q1	$373K	Buy	+23,180	New	+$401K	0.03%	527
2023 Q3	–	Sell	-10,910	Closed	-$231K	–	1942
2023 Q2	$231K	Buy	+10,910	New	+$233K	0.02%	737

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Virtu Financial's VRNA Position: Q4 2025 in Review

Virtu Financial sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 35,703 shares — an estimated $3.81M sold.

Virtu Financial first reported a position in VRNA in Q2 2023 and held it in 5 quarters. The position peaked at $3.81M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Virtu Financial reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Virtu Financial sold 35,703 Verona Pharma shares in Q4 2025, an estimated $3.81M.
Virtu Financial first reported a position in Verona Pharma in Q2 2023 and held it in 5 quarters.
Virtu Financial's Verona Pharma position peaked at $3.81M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Virtu Financial's 13F filing for Q4 2025, filed 23 Feb 2026.